nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroxyaluminium—Hyperammonaemia—Topiramate—obesity	0.0334	0.063	CcSEcCtD
Dihydroxyaluminium—VDAC1—hindbrain—obesity	0.0301	0.0642	CbGeAlD
Dihydroxyaluminium—VDAC2—respiratory system—obesity	0.0232	0.0495	CbGeAlD
Dihydroxyaluminium—VDAC3—islet of Langerhans—obesity	0.0205	0.0437	CbGeAlD
Dihydroxyaluminium—VDAC1—islet of Langerhans—obesity	0.0195	0.0415	CbGeAlD
Dihydroxyaluminium—VDAC3—respiratory system—obesity	0.0193	0.0412	CbGeAlD
Dihydroxyaluminium—VDAC1—respiratory system—obesity	0.0184	0.0392	CbGeAlD
Dihydroxyaluminium—VDAC2—cardiovascular system—obesity	0.0178	0.0379	CbGeAlD
Dihydroxyaluminium—Blindness transient—Topiramate—obesity	0.0172	0.0325	CcSEcCtD
Dihydroxyaluminium—Pulmonary congestion—Bupropion—obesity	0.0164	0.0309	CcSEcCtD
Dihydroxyaluminium—VDAC3—adrenal cortex—obesity	0.0162	0.0346	CbGeAlD
Dihydroxyaluminium—VDAC2—adipose tissue—obesity	0.0157	0.0334	CbGeAlD
Dihydroxyaluminium—VDAC1—adrenal cortex—obesity	0.0154	0.0329	CbGeAlD
Dihydroxyaluminium—VDAC3—cardiovascular system—obesity	0.0148	0.0316	CbGeAlD
Dihydroxyaluminium—VDAC2—digestive system—obesity	0.0148	0.0315	CbGeAlD
Dihydroxyaluminium—VDAC1—cardiovascular system—obesity	0.0141	0.03	CbGeAlD
Dihydroxyaluminium—VDAC2—adrenal gland—obesity	0.0141	0.03	CbGeAlD
Dihydroxyaluminium—Respiratory tract congestion—Bupropion—obesity	0.0135	0.0255	CcSEcCtD
Dihydroxyaluminium—TNNC1—adrenal cortex—obesity	0.0132	0.0282	CbGeAlD
Dihydroxyaluminium—VDAC3—pituitary gland—obesity	0.0131	0.028	CbGeAlD
Dihydroxyaluminium—VDAC3—adipose tissue—obesity	0.0131	0.0278	CbGeAlD
Dihydroxyaluminium—VDAC1—pituitary gland—obesity	0.0125	0.0266	CbGeAlD
Dihydroxyaluminium—VDAC1—adipose tissue—obesity	0.0124	0.0265	CbGeAlD
Dihydroxyaluminium—VDAC3—digestive system—obesity	0.0123	0.0262	CbGeAlD
Dihydroxyaluminium—VDAC2—endocrine gland—obesity	0.0122	0.026	CbGeAlD
Dihydroxyaluminium—TNNC1—cardiovascular system—obesity	0.0121	0.0257	CbGeAlD
Dihydroxyaluminium—VDAC3—adrenal gland—obesity	0.0117	0.025	CbGeAlD
Dihydroxyaluminium—VDAC1—digestive system—obesity	0.0117	0.0249	CbGeAlD
Dihydroxyaluminium—VDAC1—adrenal gland—obesity	0.0111	0.0238	CbGeAlD
Dihydroxyaluminium—VDAC2—liver—obesity	0.011	0.0234	CbGeAlD
Dihydroxyaluminium—TNNC1—pituitary gland—obesity	0.0107	0.0228	CbGeAlD
Dihydroxyaluminium—TNNC1—adipose tissue—obesity	0.0107	0.0227	CbGeAlD
Dihydroxyaluminium—VDAC3—endocrine gland—obesity	0.0102	0.0217	CbGeAlD
Dihydroxyaluminium—VDAC1—endocrine gland—obesity	0.00967	0.0206	CbGeAlD
Dihydroxyaluminium—TNNC1—adrenal gland—obesity	0.00955	0.0204	CbGeAlD
Dihydroxyaluminium—Urinary retention—Phenylpropanolamine—obesity	0.00924	0.0174	CcSEcCtD
Dihydroxyaluminium—Polyuria—Diethylpropion—obesity	0.00921	0.0174	CcSEcCtD
Dihydroxyaluminium—VDAC3—liver—obesity	0.00916	0.0195	CbGeAlD
Dihydroxyaluminium—VDAC1—liver—obesity	0.00872	0.0186	CbGeAlD
Dihydroxyaluminium—Lung disorder—Sibutramine—obesity	0.008	0.0151	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Phentermine—obesity	0.00783	0.0148	CcSEcCtD
Dihydroxyaluminium—Urinary retention—Cimetidine—obesity	0.00732	0.0138	CcSEcCtD
Dihydroxyaluminium—Cardiovascular disorder—Orlistat—obesity	0.00666	0.0126	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Phendimetrazine—obesity	0.00645	0.0122	CcSEcCtD
Dihydroxyaluminium—Cardiovascular disorder—Sibutramine—obesity	0.00645	0.0122	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Methamphetamine—obesity	0.00621	0.0117	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Benzphetamine—obesity	0.00598	0.0113	CcSEcCtD
Dihydroxyaluminium—Acidosis—Topiramate—obesity	0.00568	0.0107	CcSEcCtD
Dihydroxyaluminium—Cardiovascular disorder—Bupropion—obesity	0.00562	0.0106	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Phenylpropanolamine—obesity	0.00551	0.0104	CcSEcCtD
Dihydroxyaluminium—Salivary hypersecretion—Sibutramine—obesity	0.0055	0.0104	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Phendimetrazine—obesity	0.00545	0.0103	CcSEcCtD
Dihydroxyaluminium—Urticaria—Methamphetamine—obesity	0.00505	0.00954	CcSEcCtD
Dihydroxyaluminium—Encephalopathy—Topiramate—obesity	0.0049	0.00925	CcSEcCtD
Dihydroxyaluminium—Urticaria—Benzphetamine—obesity	0.00487	0.0092	CcSEcCtD
Dihydroxyaluminium—Polyuria—Orlistat—obesity	0.00484	0.00913	CcSEcCtD
Dihydroxyaluminium—Salivary hypersecretion—Bupropion—obesity	0.0048	0.00905	CcSEcCtD
Dihydroxyaluminium—Phlebitis—Sibutramine—obesity	0.00477	0.00901	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Methamphetamine—obesity	0.00469	0.00884	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Phenylpropanolamine—obesity	0.00466	0.0088	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Diethylpropion—obesity	0.00459	0.00866	CcSEcCtD
Dihydroxyaluminium—Oedema—Phentermine—obesity	0.00457	0.00862	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Benzphetamine—obesity	0.00452	0.00853	CcSEcCtD
Dihydroxyaluminium—Coma—Bupropion—obesity	0.00451	0.00852	CcSEcCtD
Dihydroxyaluminium—Thirst—Orlistat—obesity	0.00446	0.00843	CcSEcCtD
Dihydroxyaluminium—Hypotension—Phenylpropanolamine—obesity	0.00446	0.00842	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Phentermine—obesity	0.00446	0.00842	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Methamphetamine—obesity	0.00435	0.00821	CcSEcCtD
Dihydroxyaluminium—Thirst—Sibutramine—obesity	0.00432	0.00815	CcSEcCtD
Dihydroxyaluminium—Convulsion—Diethylpropion—obesity	0.00422	0.00796	CcSEcCtD
Dihydroxyaluminium—Dizziness—Methamphetamine—obesity	0.00421	0.00794	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Benzphetamine—obesity	0.0042	0.00792	CcSEcCtD
Dihydroxyaluminium—Phlebitis—Bupropion—obesity	0.00416	0.00785	CcSEcCtD
Dihydroxyaluminium—Polyuria—Bupropion—obesity	0.00408	0.0077	CcSEcCtD
Dihydroxyaluminium—Dizziness—Benzphetamine—obesity	0.00406	0.00765	CcSEcCtD
Dihydroxyaluminium—Urinary retention—Sibutramine—obesity	0.00391	0.00738	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Diethylpropion—obesity	0.00388	0.00732	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Phendimetrazine—obesity	0.00382	0.00722	CcSEcCtD
Dihydroxyaluminium—Dehydration—Sibutramine—obesity	0.00382	0.00722	CcSEcCtD
Dihydroxyaluminium—Visual disturbance—Bupropion—obesity	0.00378	0.00714	CcSEcCtD
Dihydroxyaluminium—Thirst—Bupropion—obesity	0.00377	0.00711	CcSEcCtD
Dihydroxyaluminium—Dizziness—Phendimetrazine—obesity	0.0037	0.00698	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Cimetidine—obesity	0.00369	0.00697	CcSEcCtD
Dihydroxyaluminium—Nausea—Benzphetamine—obesity	0.00364	0.00688	CcSEcCtD
Dihydroxyaluminium—Urticaria—Phentermine—obesity	0.00363	0.00685	CcSEcCtD
Dihydroxyaluminium—Cardiovascular disorder—Topiramate—obesity	0.00358	0.00676	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Phenylpropanolamine—obesity	0.00352	0.00664	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Sibutramine—obesity	0.00346	0.00653	CcSEcCtD
Dihydroxyaluminium—Urinary retention—Bupropion—obesity	0.00341	0.00643	CcSEcCtD
Dihydroxyaluminium—Dehydration—Bupropion—obesity	0.00333	0.00629	CcSEcCtD
Dihydroxyaluminium—Nausea—Phendimetrazine—obesity	0.00332	0.00627	CcSEcCtD
Dihydroxyaluminium—Urticaria—Diethylpropion—obesity	0.00316	0.00596	CcSEcCtD
Dihydroxyaluminium—Dizziness—Phenylpropanolamine—obesity	0.00316	0.00596	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Phentermine—obesity	0.00313	0.0059	CcSEcCtD
Dihydroxyaluminium—Salivary hypersecretion—Topiramate—obesity	0.00306	0.00577	CcSEcCtD
Dihydroxyaluminium—Vomiting—Phenylpropanolamine—obesity	0.00304	0.00573	CcSEcCtD
Dihydroxyaluminium—Dizziness—Phentermine—obesity	0.00302	0.0057	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Cimetidine—obesity	0.00299	0.00564	CcSEcCtD
Dihydroxyaluminium—Vomiting—Phentermine—obesity	0.0029	0.00548	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Sibutramine—obesity	0.00285	0.00538	CcSEcCtD
Dihydroxyaluminium—Nausea—Phenylpropanolamine—obesity	0.00284	0.00535	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Cimetidine—obesity	0.00279	0.00526	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Sibutramine—obesity	0.00274	0.00517	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Diethylpropion—obesity	0.00272	0.00513	CcSEcCtD
Dihydroxyaluminium—Nausea—Phentermine—obesity	0.00271	0.00512	CcSEcCtD
Dihydroxyaluminium—Phlebitis—Topiramate—obesity	0.00265	0.005	CcSEcCtD
Dihydroxyaluminium—Dizziness—Diethylpropion—obesity	0.00263	0.00496	CcSEcCtD
Dihydroxyaluminium—Polyuria—Topiramate—obesity	0.0026	0.00491	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Cimetidine—obesity	0.00259	0.00488	CcSEcCtD
Dihydroxyaluminium—Chills—Sibutramine—obesity	0.00255	0.00482	CcSEcCtD
Dihydroxyaluminium—Vomiting—Diethylpropion—obesity	0.00253	0.00477	CcSEcCtD
Dihydroxyaluminium—Dizziness—Cimetidine—obesity	0.0025	0.00472	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Bupropion—obesity	0.00249	0.00469	CcSEcCtD
Dihydroxyaluminium—Back pain—Orlistat—obesity	0.00247	0.00467	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Orlistat—obesity	0.00241	0.00455	CcSEcCtD
Dihydroxyaluminium—Visual disturbance—Topiramate—obesity	0.00241	0.00455	CcSEcCtD
Dihydroxyaluminium—Vomiting—Cimetidine—obesity	0.0024	0.00454	CcSEcCtD
Dihydroxyaluminium—Thirst—Topiramate—obesity	0.0024	0.00453	CcSEcCtD
Dihydroxyaluminium—Back pain—Sibutramine—obesity	0.00239	0.00452	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Bupropion—obesity	0.00239	0.00451	CcSEcCtD
Dihydroxyaluminium—Nausea—Diethylpropion—obesity	0.00236	0.00446	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Sibutramine—obesity	0.00233	0.0044	CcSEcCtD
Dihydroxyaluminium—Vertigo—Orlistat—obesity	0.0023	0.00434	CcSEcCtD
Dihydroxyaluminium—Hyponatraemia—Topiramate—obesity	0.00229	0.00433	CcSEcCtD
Dihydroxyaluminium—Nausea—Cimetidine—obesity	0.00225	0.00424	CcSEcCtD
Dihydroxyaluminium—Chills—Bupropion—obesity	0.00222	0.0042	CcSEcCtD
Dihydroxyaluminium—Vertigo—Sibutramine—obesity	0.00222	0.0042	CcSEcCtD
Dihydroxyaluminium—Convulsion—Orlistat—obesity	0.00222	0.00418	CcSEcCtD
Dihydroxyaluminium—Urinary retention—Topiramate—obesity	0.00217	0.0041	CcSEcCtD
Dihydroxyaluminium—Convulsion—Sibutramine—obesity	0.00215	0.00405	CcSEcCtD
Dihydroxyaluminium—Dehydration—Topiramate—obesity	0.00212	0.00401	CcSEcCtD
Dihydroxyaluminium—Oedema—Orlistat—obesity	0.00209	0.00394	CcSEcCtD
Dihydroxyaluminium—Back pain—Bupropion—obesity	0.00209	0.00394	CcSEcCtD
Dihydroxyaluminium—Infection—Orlistat—obesity	0.00207	0.00392	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Bupropion—obesity	0.00203	0.00384	CcSEcCtD
Dihydroxyaluminium—Oedema—Sibutramine—obesity	0.00202	0.00381	CcSEcCtD
Dihydroxyaluminium—Infection—Sibutramine—obesity	0.00201	0.00379	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Sibutramine—obesity	0.00197	0.00372	CcSEcCtD
Dihydroxyaluminium—Vertigo—Bupropion—obesity	0.00194	0.00366	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Topiramate—obesity	0.00192	0.00363	CcSEcCtD
Dihydroxyaluminium—Hypotension—Sibutramine—obesity	0.00189	0.00356	CcSEcCtD
Dihydroxyaluminium—Convulsion—Bupropion—obesity	0.00187	0.00353	CcSEcCtD
Dihydroxyaluminium—Pain—Orlistat—obesity	0.00179	0.00337	CcSEcCtD
Dihydroxyaluminium—Oedema—Bupropion—obesity	0.00176	0.00333	CcSEcCtD
Dihydroxyaluminium—Infection—Bupropion—obesity	0.00175	0.0033	CcSEcCtD
Dihydroxyaluminium—Pain—Sibutramine—obesity	0.00173	0.00326	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Bupropion—obesity	0.00172	0.00325	CcSEcCtD
Dihydroxyaluminium—Urticaria—Orlistat—obesity	0.00166	0.00313	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Orlistat—obesity	0.00165	0.00312	CcSEcCtD
Dihydroxyaluminium—Hypotension—Bupropion—obesity	0.00165	0.00311	CcSEcCtD
Dihydroxyaluminium—Urticaria—Sibutramine—obesity	0.00161	0.00303	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Sibutramine—obesity	0.0016	0.00302	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Topiramate—obesity	0.00158	0.00299	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Orlistat—obesity	0.00154	0.0029	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Topiramate—obesity	0.00152	0.00287	CcSEcCtD
Dihydroxyaluminium—Pain—Bupropion—obesity	0.00151	0.00284	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Sibutramine—obesity	0.00149	0.00281	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Orlistat—obesity	0.00143	0.0027	CcSEcCtD
Dihydroxyaluminium—Chills—Topiramate—obesity	0.00142	0.00268	CcSEcCtD
Dihydroxyaluminium—Urticaria—Bupropion—obesity	0.0014	0.00264	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Bupropion—obesity	0.00139	0.00263	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Sibutramine—obesity	0.00138	0.00261	CcSEcCtD
Dihydroxyaluminium—Dizziness—Orlistat—obesity	0.00138	0.00261	CcSEcCtD
Dihydroxyaluminium—Dizziness—Sibutramine—obesity	0.00134	0.00252	CcSEcCtD
Dihydroxyaluminium—Back pain—Topiramate—obesity	0.00133	0.00251	CcSEcCtD
Dihydroxyaluminium—Vomiting—Orlistat—obesity	0.00133	0.00251	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Bupropion—obesity	0.0013	0.00245	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Topiramate—obesity	0.0013	0.00245	CcSEcCtD
Dihydroxyaluminium—Vomiting—Sibutramine—obesity	0.00128	0.00243	CcSEcCtD
Dihydroxyaluminium—Nausea—Orlistat—obesity	0.00124	0.00234	CcSEcCtD
Dihydroxyaluminium—Vertigo—Topiramate—obesity	0.00124	0.00233	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Bupropion—obesity	0.00121	0.00228	CcSEcCtD
Dihydroxyaluminium—Nausea—Sibutramine—obesity	0.0012	0.00227	CcSEcCtD
Dihydroxyaluminium—Convulsion—Topiramate—obesity	0.00119	0.00225	CcSEcCtD
Dihydroxyaluminium—Dizziness—Bupropion—obesity	0.00116	0.0022	CcSEcCtD
Dihydroxyaluminium—Oedema—Topiramate—obesity	0.00112	0.00212	CcSEcCtD
Dihydroxyaluminium—Vomiting—Bupropion—obesity	0.00112	0.00211	CcSEcCtD
Dihydroxyaluminium—Infection—Topiramate—obesity	0.00111	0.0021	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Topiramate—obesity	0.0011	0.00207	CcSEcCtD
Dihydroxyaluminium—Hypotension—Topiramate—obesity	0.00105	0.00198	CcSEcCtD
Dihydroxyaluminium—Nausea—Bupropion—obesity	0.00105	0.00198	CcSEcCtD
Dihydroxyaluminium—Pain—Topiramate—obesity	0.00096	0.00181	CcSEcCtD
Dihydroxyaluminium—Urticaria—Topiramate—obesity	0.000892	0.00168	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Topiramate—obesity	0.000887	0.00167	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Topiramate—obesity	0.000827	0.00156	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Topiramate—obesity	0.000768	0.00145	CcSEcCtD
Dihydroxyaluminium—Dizziness—Topiramate—obesity	0.000742	0.0014	CcSEcCtD
Dihydroxyaluminium—Vomiting—Topiramate—obesity	0.000714	0.00135	CcSEcCtD
Dihydroxyaluminium—Nausea—Topiramate—obesity	0.000667	0.00126	CcSEcCtD
Dihydroxyaluminium—VDAC1—Mitochondrial protein import—CS—obesity	0.000317	0.326	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—MBOAT4—obesity	5.98e-05	0.0615	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—CPE—obesity	5.33e-05	0.0548	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—CPB2—obesity	4.04e-05	0.0415	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—CS—obesity	4.04e-05	0.0415	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—IGFBP2—obesity	3.85e-05	0.0396	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—FFAR4—obesity	3.85e-05	0.0396	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—GFPT1—obesity	3.69e-05	0.038	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—GH1—obesity	3.43e-05	0.0353	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—STS—obesity	2.92e-05	0.03	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—DPP4—obesity	2.8e-05	0.0288	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—GIP—obesity	2.69e-05	0.0277	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—PCSK1—obesity	2.6e-05	0.0268	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—IGFBP1—obesity	2.02e-05	0.0208	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—IGFBP3—obesity	1.76e-05	0.0181	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—GHRL—obesity	1.49e-05	0.0154	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—BCHE—obesity	1.49e-05	0.0154	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—ACE—obesity	1.45e-05	0.0149	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—TCF7L2—obesity	1.39e-05	0.0143	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—GCG—obesity	1.37e-05	0.0141	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—PLG—obesity	1.27e-05	0.0131	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—GNB3—obesity	1.18e-05	0.0121	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—IGF2—obesity	1.16e-05	0.0119	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—AGT—obesity	9.17e-06	0.00944	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—LEP—obesity	8.99e-06	0.00925	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—F2—obesity	8.48e-06	0.00872	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—POMC—obesity	7.72e-06	0.00795	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—INS—obesity	7.68e-06	0.0079	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—CCL2—obesity	7.56e-06	0.00777	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—IGF1—obesity	7.43e-06	0.00764	CbGpPWpGaD
